The company confirmed the publication of its successful clinical case series in Frontiers in Immunology, a peer-reviewed scientific journal, and received confirmation from the U.S. Food and Drug ...
A small prospective, double-blind study in children with IgE-mediated cow’s milk allergy (CMA) found that heated cow’s milk ...
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer (PFE) is running a Phase 2 study titled “AN ...
Vietnam Investment Review on MSN
Ascletis Announces U.S. FDA IND Clearance for 13-Week Phase II Study of Its Oral Small Molecule GLP-1, ASC30, in Participants with Diabetes
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that it recently received the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for the Phase II ...
Neurocrine Biosciences (NBIX) announced an update on their ongoing clinical study.
Neumora Therapeutics (NMRA) announced results from its Phase 1b signal-seeking study of NMRA-511 in people with Alzheimer’s disease agitation.
The first platform trial for amyotrophic lateral sclerosis (ALS), which individually evaluated four experimental drugs, failed to meet key primary endpoints. Still, investigators view the trial as ...
“Can the blind lead the blind? Shall they not both fall into the pit?” Luke 6:39 While “the blind leading the blind” has become an often-used idiom of incompetency and ineffectiveness, the “randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback